Molecular imaging to predict ventricular arrhythmia in heart failure

Area of Science:

• Cardiology
• Nuclear Medicine
• Medical Imaging

Background:

• Ventricular tachycardia (VT) is a primary cause of sudden cardiac death (SCD) in heart failure (HF) patients.
• Current criteria like left ventricular ejection fraction (LVEF) and NYHA class have limited accuracy in predicting appropriate implantable cardioverter defibrillator (ICD) therapy, with only 35% receiving beneficial action.
• Refined selection criteria are crucial for optimizing ICD implantation in HF patients.

Purpose of the Study:

• To review the literature on the utility of molecular neuronal cardiac imaging.
• To assess the value of autonomic nervous system imaging in predicting ventricular arrhythmias.
• To explore improved patient selection for ICD therapy in heart failure.

Main Methods:

• Literature review of studies investigating molecular imaging of the cardiac autonomic nervous system.
• Analysis of imaging techniques targeting neuronal function in the heart.
• Correlation of imaging findings with the occurrence of ventricular arrhythmias and sudden cardiac death.

Main Results:

• Molecular imaging of the autonomic nervous system shows promise in identifying HF patients at higher risk for ventricular arrhythmias.
• The autonomic nervous system plays a critical role in HF progression and cardiac electro-mechanical regulation.
• Current selection criteria for ICDs are insufficient, highlighting the need for advanced predictive tools.

Conclusions:

• Molecular neuronal cardiac imaging offers a valuable tool for refining patient selection for ICD implantation in heart failure.
• This imaging modality can improve the prediction of ventricular arrhythmias and reduce sudden cardiac death.
• Further research into autonomic nervous system imaging is warranted to enhance risk stratification in HF.